Tags : Collaboration

ImmunoGen Signs an Agreement with Huadong to Develop & Commercialize

Tuba Khan October 20, 2020

Shots: ImmunoGen to receive $40M up front, ~$265M as development, regulatory & commercial milestones and is eligible to receive royalties on sales of mirvetuximab in Greater China and will retain all rights to mirvetuximab in the US & ROW The collaboration accelerates the development path for mirvetuximab in Greater China and expands Huadong’s oncology portfolio […]Read More

Regulatory

GSK Signs an Agreement with Vir Biotechnology to Develop Solutions

Vartika Singh October 7, 2020

Shots: GSK will make equity investment to gain access to Vir’s technology of $250M, priced at $37.73 (a 10% premium to closing share price on March 27, 2020). The equity investment and collaboration will complete at the same time & are conditional upon customary conditions including regulatory review by appropriate regulatory agencies under Hart-Scott-Rodino Act […]Read More

Pharma

Pfizer Signs an Agreement with SpringWorks to Evaluate Nirogacestat +

Tuba Khan October 6, 2020

Shots: Pfizer to sponsor & conduct P-Ib/II study evaluating the safety, tolerability, and preliminary efficacy of dual regimen and will assume costs of study & other expenses related to IP rights. The companies will form a joint development committee to manage clinical study which is anticipated to commence in H1’21 The focus of the collaboration […]Read More

Clinical Trials

Pfizer Initiates Clinical Study of Eighth Candidate Emerges Under the

Tuba Khan September 28, 2020

Shots: Sosei Heptares to receive $5M as milestones triggered by the dosing of the first subject in a clinical trial. In Jun’2019, Pfizer nominated the candidate for advancement and granted $3M as milestones The companies collaborated in 2015 to develop therapies directed at up to ten GPCR targets across multiple therapeutic areas. The collaboration […]Read More

Pharma

IDEAYA and Pfizer Expand CTC and Supply Agreement for Solid

Tuba Khan September 24, 2020

Shots: The companies have expanded their clinical trial collaboration and supply agreement for IDE196 and crizotinib. The study will evaluate combination therapy in patients with solid tumors having GNAQ or GNA11 mutations (GNAQ/11), including MUM, skin melanoma, lung cancer, and colorectal cancer The two global companies have established JDC and there will be joint decision […]Read More

Biotech

Merck Signs a Second Oncology Collaboration with Highlight Therapeutics

Tuba Khan September 3, 2020

Shots: The P-II Spotlight 203 study will evaluate the combination of BO-112 (intra-tumoral administration) + Keytruda (pembrolizumab) with CR or PR as its 1EPs. The study will evaluate disease control rates, DoR, PFS, OS, as well as safety, tolerability, and PK of the therapy in ~40 patients The collaboration will focus on the evaluation of […]Read More

Biotech

Evotec and Centogene Expand their Collaboration to Target Gaucher Disease

Vartika Singh August 20, 2020

Shots: The two companies will work together to research, discover, and develop therapeutic options related to the deficiency of the protein GBA which is a gene linked to Gaucher disease The collaboration will combine Evotec’s iPSC platform and drug discovery and development capabilities with Centogene’s global rare disease platform, including iPSC lines The collaboration follows […]Read More

Biotech COVID-19

Eli Lilly in Collaboration with NIAID Initiate P-III Study of

Tuba Khan August 4, 2020

Shots: Eli Lilly initiates P-III BLAZE-2 study assessing LY-CoV555 to prevent SARS-CoV-2 infection and COVID-19 in residents and staff at long-term care facilities in the US (skilled nursing facilities, commonly referred to as nursing homes, and assisted living facilities) The company will enroll up to ~2400 patients and test whether a single dose of LY-CoV555 […]Read More

MedTech

Roche Signs RWD Collaboration with PicnicHealth to Create Personalized Treatment

Tuba Khan July 20, 2020

Shots: The real-world evidence partnership will allow the Roche to access PicnicHealth’s set of de-identified patient records to gain insights on certain diseases and treatments The collaboration will initially focus on MS and may be extended to support Huntington’s disease (HD), paroxysmal nocturnal hemoglobinuria (PNH), and hemophilia The companies signed a multi-year collaboration that combines […]Read More

Pharma

Merck KGaA Takes an Early Option in its Existing Immuno-Oncology

Tuba Khan July 17, 2020

Shots: F-star to receive option exercise payment and will be eligible to get milestones and royalties on net sales of therapies resulting from the collaboration. Merck KGaA exercises its option to license a preclinical program in its existing agreement with F-star Merck KGaA will be responsible for the development and commercialization of the preclinical program […]Read More

Amgen Collaborates with Evoq to Develop Novel Therapies for Autoimmune Disorders

Gilead Collaborates with VIR to Evaluate Combination Therapy for Chronic Hepatitis B Virus

Janssen Signs a Research Agreement with TenNor to Develop Treatments for Nontuberculous Mycobacteria Diseases

Boehringer Ingelheim Collaborates with Cure Genetics to Develop Next-Generation Liver-Targeted Gene Therapy

Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia

Henlius’ HLX15 (biosimilar, daratumumab) Receives IND Approval for Multiple Myeloma in China

Celltrion Report Results of CT-P59 in P-II/III Study for COVID-19

The US Government to Purchase Additional Doses of Regeneron’s Casirivimab and Imdevimab to Combat COVID-19

Tessa’s CD30 CAR-T Therapy Receives EMA’s PRIME Designation for Relapsed or Refractory Classical Hodgkin Lymphoma

Genmab’s Darzalex Faspro (daratumumab and hyaluronidase-fihj) Receives the US FDA’s Approval for Patients with Newly Diagnosed Light-chain (AL) Amyloidosis

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Nanobiotix Presents Results of NBTXR3 (PEP503) in P-Ib/II Study for Rectal Cancer at ASCO-GI 2021

Tags : Collaboration

ImmunoGen Signs an Agreement with Huadong to Develop & Commercialize

GSK Signs an Agreement with Vir Biotechnology to Develop Solutions

Pfizer Signs an Agreement with SpringWorks to Evaluate Nirogacestat +

Pfizer Initiates Clinical Study of Eighth Candidate Emerges Under the

IDEAYA and Pfizer Expand CTC and Supply Agreement for Solid

Merck Signs a Second Oncology Collaboration with Highlight Therapeutics

Evotec and Centogene Expand their Collaboration to Target Gaucher Disease

Eli Lilly in Collaboration with NIAID Initiate P-III Study of

Roche Signs RWD Collaboration with PicnicHealth to Create Personalized Treatment

Merck KGaA Takes an Early Option in its Existing Immuno-Oncology

Latest Posts

ViewPoints Interview: Kaia Health’s Jonas Duss Shares Insights on COPD Pulmonary Rehabilitation App

Philips to Acquire Capsule Technologies for ~$635M

Innovent Out Licenses Byvasda’s (biosimilar, bevacizumab) Development and Commercialization Rights to PT Etana in Indonesia

Grifols to Evaluate New Immunoglobulin Therapy Against COVID-19 in Spain

Tags : Collaboration

Latest Posts

Categories

Related Topics